Xenon Pharmaceuticals Inc. (XENE)
NASDAQ
Xenon Pharmaceuticals Inc. annual/quarterly long term debt history from 2017 to 2019. Long term debt refers to financial obligations that are due more than one year in the future.
- Xenon Pharmaceuticals Inc. long term debt for the quarter ending December 31, 2019 were 10.9M, a 78.39% increase year-over-year.
- Xenon Pharmaceuticals Inc. long term debt for 2019 were 10.9M, a 78.39% increase from 2017.
- Xenon Pharmaceuticals Inc. long term debt for 2017 were 6.1M.
Long Term Debt
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Xenon Pharmaceuticals Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2019 | $11 |
| 2017 | $6 |
| Xenon Pharmaceuticals Inc. Quarterly Long Term Debt (Millions of US $) | |
|---|---|
| 2019-12-31 | $11 |
| 2017-12-31 | $6 |
Xenon Pharmaceuticals Inc. Long Term Debt — FAQ
Xenon Pharmaceuticals Inc. (XENE) long term debt over the last 13 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see XENE's long term debt history?
The chart and table above show Xenon Pharmaceuticals Inc.'s long term debt by year and by quarter, including the growth rate.